04:32 PM EDT, 08/19/2024 (MT Newswires) -- Titan Pharmaceuticals ( TTNP ) said Monday it has signed a merger agreement for a business combination with KE Sdn. Bhd.
Titan said that it will be combined with KE in a "reverse merger" transaction if the agreement is approved by Titan and KE's shareholders and other closing conditions are met.
Seow Gim Shen, Titan's board chair and chief executive, owns about 47% of KE's outstanding shares, Titan said. Seow is the sole stockholder of The Sire Group, which is the holder of Series AA preferred stock convertible into 150,087 shares of Titan stock.